Optical Coherence Tomography Angiography for Choroidal and Vitreoretinal Disorders – Part 2

Author(s): Sanjay Marasini and Miguel A. Quiroz-Reyes * .

DOI: 10.2174/9789815196658123010011

OCT-A Findings and Usefulness in Alzheimer's Disease, Parkinson's Disease, and Systemic Lupus Erythematosus

Pp: 170-188 (19)

Buy Chapters

* (Excluding Mailing and Handling)

  • * (Excluding Mailing and Handling)

Abstract

SHS investigation development is considered from the geographical and historical viewpoint. 3 stages are described. Within Stage 1 the work was carried out in the Department of the Institute of Chemical Physics in Chernogolovka where the scientific discovery had been made. At Stage 2 the interest to SHS arose in different cities and towns of the former USSR. Within Stage 3 SHS entered the international scene. Now SHS processes and products are being studied in more than 50 countries.

Abstract

The eye is a window to the brain because of its inherent connection to the central nervous system (CNS). Several brain disorders manifest as ophthalmic abnormalities and can be detected through a detailed assessment of the eyes. In the last decade, extensive evaluation of retinal microvascular changes using optical coherence tomography angiography (OCT-A) has been performed for several diseases, such as Parkinson's disease, Alzheimer's disease, and systemic lupus erythematosus. Although the results from the available studies are conflicting (mainly due to heterogeneous study populations), they agree on the applicability of this technology for the early identification of these diseases. This chapter summarizes the OCT-A screening and monitoring uses for these diseases and hypotheses for the potential identification of disease characteristics.

We recommend

Favorable 70-S: Investigation Branching Arrow

Authors:Bentham Science Books